Skip to main content
. 2012 Oct;80(10):3389–3398. doi: 10.1128/IAI.00562-12

Fig 7.

Fig 7

Immunization of mice with the Coa4/vWbp2 vaccine and spectrum of disease protection against different S. aureus isolates. (A) Coa4/vWbp2 or mock (PBS) vaccine was used to immunize BALB/c mice (n = 5) with a prime-boost regimen. Immune sera were analyzed by an ELISA for the reactivity of mouse serum IgG toward purified Coa4 and vWbp2. (B to F) Cohorts of BALB/c mice (n = 20 in panel B and n = 10 in panels C to F) were immunized with a prime-boost regimen of purified Coa4/vWbp2 or mock vaccine (B) and challenged by intravenous injection with S. aureus USA300 (B), N315 (C), MW2 (D), CowanI (E), or WIS (F). The survival of animals was monitored over 10 days.